Dechra completed the acquisition of Med-Pharmex from DW Healthcare Partners for $260m.

Dechra, a global specialist in veterinary pharmaceuticals and related products business, completed the acquisition of Med-Pharmex, a manufacturer of veterinary drugs for the animal health industry, from DW Healthcare Partners, a private equity company, for $260m. "I am delighted that we have completed the acquisition of Med-Pharmex, a company that I have been in dialogue with for a number of years. The US market is highly consolidated, therefore this is a unique opportunity to add several new products to our portfolio, enter the US FAP market and improve the manufacturing footprint for our North American business," Ian Page, Dechra CEO.